Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Spontaneous hair regrowth in alopecia areata is possible but varies greatly among individuals.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Intralesional corticosteroids may be more effective than cryotherapy for hair regrowth in alopecia areata.

In this study, a triple wavelength laser was found to be highly effective and well-tolerated for reducing hair in Indian women with Fitzpatrick skin types III and IV, achieving an average hair count reduction of 86.5%, with only mild and transient adverse effects observed.

This study observed no significant relationship between androgenetic alopecia and psychosocial or sexual symptoms among men aged 33 to 35 in the Northern Finland Birth Cohort 1986, challenging previous findings of such associations.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

The Paxbp1 gene is crucial for healthy hair follicles.

This study found that individuals with hospital-treated alopecia areata in Denmark had increased standardized incidence rates of serious infections, herpes zoster infections, lymphoma, cardiovascular events, and death compared to the age- and sex-matched general population.

Topical minoxidil may cause cherry hemangiomas in some users.

This review evaluates 21 studies on minoxidil-induced allergic contact dermatitis, finding that some patients with contact dermatitis symptoms like erythema and pruritus are sensitized to minoxidil or its vehicle components and should consider patch testing and alternative formulations for proper management.

In this real-world study, JAK inhibitors like abrocitinib and tofacitinib led to substantial hair regrowth in 61% of alopecia areata patients over a median of 16 months, with 75% of non-responders achieving regrowth after switching medications; however, two serious adverse events were noted.

This cross-sectional survey found that individuals with alopecia areata and androgenetic alopecia perceived stigmatization and impaired quality of life, with greater stigma reported in German-speaking participants; factors like gender, age, and disease severity influenced stigmatization levels.

In this study, infants born to mothers with alopecia areata had a higher risk of adverse birth outcomes, including preterm birth, low birth weight, Caesarean section, and congenital malformations.

This review discusses the promising role of JAK inhibitors in managing alopecia areata, reporting significant hair regrowth and acceptable safety profiles but noting the need for further research on dosing and long-term safety.

In this study, oral minoxidil treatment significantly increased serum VEGF levels and improved hair growth measures compared to a control group, suggesting its potential as an effective approach for promoting hair regrowth in androgenetic alopecia.

This study in a real-world setting found that baricitinib was effectively reducing disease severity in severe alopecia areata patients over 52 weeks, with 37.20% of participants achieving significant improvement and 72.40% experiencing mild or no adverse events.

This study found a high prevalence of alopecia in adolescents from northern Sudan, especially among females, and identified iron deficiency as significantly associated with the condition.

In this case report, a patient developed facial zona zoster as an unexpected complication following cryotherapy, adding to the list of known adverse effects such as dyspigmentation, scar formation, and hair loss.

This case report describes radiation-induced alopecia in a patient following a fluoroscopy-guided procedure, with complete hair regrowth after six months of topical minoxidil treatment.

Topical minoxidil effectively stimulates hair growth in men with hair loss.

This study reports that folliculitis decalvans and lichen planopilaris phenotypic spectrum is an underdiagnosed form of cicatricial alopecia, potentially treatable with anti-inflammatory drugs used for lichen planopilaris.

This retrospective cohort study reported that oral tofacitinib was effective in treating alopecia areata, with 83.2% of patients showing improvement and 16.0% achieving complete remission. Earlier intervention and previous hair regrowth were linked to better outcomes, and no severe adverse events were observed.

This review suggests that metformin, known for its antidiabetic uses, may benefit chronic inflammatory skin diseases like acne vulgaris, hidradenitis suppurativa, and rosacea due to its multiple therapeutic properties, although more research is needed to confirm its efficacy in dermatology.

Minoxidil and platelet-rich plasma can help turn thin hair into thicker hair in male pattern baldness.

This study found that patients with severe alopecia areata had significantly lower serum zinc levels compared to healthy controls, and a negative correlation between zinc levels and disease severity was observed, suggesting that zinc assessment and supplementation trials may be warranted in this population.

This study found that pilonidal sinus disease is a common comorbidity with hidradenitis suppurativa and is linked with increased disease severity, suggesting it may serve as a sentinel event for identifying high-risk patients.

This study observed that oral tofacitinib was effective and safe for treating alopecia areata in paediatric patients, with 82% of pre-adolescent participants experiencing hair regrowth and 64% showing significant improvement in their hair loss severity scores.

This study found that royal jelly extract, popular for surgical wound healing, contains stable levels of flavonoids and phenols for up to 28 days.